Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Abivax SA - American Depositary Shares
(NQ:
ABVX
)
102.47
-7.01 (-6.40%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 27, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,757,499
Open
108.24
Bid (Size)
102.10 (100)
Ask (Size)
102.45 (500)
Prev. Close
109.48
Today's Range
102.00 - 108.43
52wk Range
4.770 - 148.83
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
2 Healthcare Stocks That Could Soar Over the Next 5 Years
↗
March 26, 2026
They could make important breakthroughs in their target markets.
Via
The Motley Fool
Abivax Announces Full Year 2025 Financial Results and Provides Business Updates
March 23, 2026
From
Abivax
Via
GlobeNewswire
Performance
YTD
-23.4%
-23.4%
1 Month
-16.9%
-16.9%
3 Month
-28.0%
-28.0%
6 Month
+23.7%
+23.7%
1 Year
+1402.5%
+1402.5%
More News
Read More
Goldman Sachs Bullish Forecast: 15% Increase in 2026 U.S. M&A Activity
March 23, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Intellectual Property
2 Healthcare Stocks to Buy Before They Get Bought Out
↗
March 20, 2026
Via
The Motley Fool
This Investor Sold $104 Million of Nuvalent Stock Amid Cancer Drug Developer's Nearly 30% Rally
↗
March 16, 2026
Via
The Motley Fool
This Biotech Attracted a $181 Million Investment During a Staggering 1,300% Stock Rally
↗
March 16, 2026
Via
The Motley Fool
This Fund Bought $28 Million of a Beaten-Down Immunotherapy Stock Last Quarter. What Should Long-Term Investors Know?
↗
March 16, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
This $64 Million Biotech Exit Seemingly Missed a 77% One-Day Surge on Gilead Takeover Deal
↗
March 16, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Biotech Stock Up Nearly 300% Draws $68.7 Million Bet as Breast Cancer Drug Targets 2027 Launch
↗
March 16, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
This Biotech Stock Up 700% Is Still a Top Holding Despite a $9.3 Million Sale Last Quarter
↗
March 16, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
What to Know About This Obesity Drug Developer That Just Drew a New $7 Million Investment
↗
March 16, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
This Biotech With a Breakout MS Drug Draws $8 Million Investment Amid 30% Stock Drop
↗
March 16, 2026
Via
The Motley Fool
This Biotech Stock Surged 75% Last Quarter and Pulled a New $9 Million Investment
↗
March 16, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
This Life Sciences Supplier Has Plunged 50% in a Year, but One Fund Bought Up $28 Million More in Stock
↗
March 16, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Supply Chain
Billionaire Steve Cohen Owns Shares of This Stock That Has Soared 1,600% in The Past Year
↗
March 10, 2026
Via
The Motley Fool
2 Reasons Abivax Stock Could 10X by 2036
↗
February 27, 2026
Via
The Motley Fool
Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease at ECCO 2026
February 21, 2026
From
Abivax
Via
GlobeNewswire
Biotech Exit: $26 Million Arcellx Sale Follows Tepid Stock Performance and Kelonia Competition
↗
February 17, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Cogent Biosciences Stock Up 346% as Fund Builds $29 Million Stake After November Phase 3 Breakthrough
↗
February 17, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Fund Discloses $35 Million Biotech Buy Amid Staggering 830% Terns Stock Surge
↗
February 17, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Biotech Stock Up 266%: This New $55 Million Bet Signals Conviction in Praxis Amid Pipeline Progress
↗
February 14, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Apogee Stock Jumps 87% in One Year as This Biotech Fund Lifts Stake to $93 Million
↗
February 14, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon.
↗
February 10, 2026
Via
The Motley Fool
Better Long-Term Buy: This Emerging Player or the Industry Leader?
↗
January 30, 2026
Via
The Motley Fool
Topics
Intellectual Property
Prediction: This Healthcare Stock Could Soar by 72% in 2026
↗
January 19, 2026
Via
The Motley Fool
Frequently Asked Questions
Is Abivax SA - American Depositary Shares publicly traded?
Yes, Abivax SA - American Depositary Shares is publicly traded.
What exchange does Abivax SA - American Depositary Shares trade on?
Abivax SA - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Abivax SA - American Depositary Shares?
The ticker symbol for Abivax SA - American Depositary Shares is ABVX on the Nasdaq Stock Market
What is the current price of Abivax SA - American Depositary Shares?
The current price of Abivax SA - American Depositary Shares is 102.47
When was Abivax SA - American Depositary Shares last traded?
The last trade of Abivax SA - American Depositary Shares was at 03/27/26 04:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.